Amino acids valine replaced

When the number of amino acids in a polypeptide chain reaches more than fifty, a protein exists. The structure of both polypeptides and proteins dictate how these biomolecules function. There are several levels of structure associated with polypeptides and proteins. The sequence of the amino acids forming the backbone of the protein is referred to as the primary structure. A different order or even a minor change in an amino acid sequence creates an entirely different molecule. Just reversing the order of amino acids in a dipeptide changes how the dipeptide functions. An example of this is sickle-cell anemia. Sickle-cell anemia is a genetic disorder that occurs when the amino acid valine replaces... 

FIGURE 19.18 Sickle-shaped red blood cells form when only one amino acid (glutamic acid) in a polypeptide chain is replaced by another amino acid (valine). These cells are less able to take up oxygen than normal cells. 

In sickle cell hemoglobin, the glutamic acid of the beta subunit is replaced by the amino acid valine (Fig. 7.11.2). Even though only this one amino acid is... 

As a further test of the etched open tubular approach for the analysis of optical isomers, another column was fabricated based on the selector naphthylethylamine that had been attached to porous silica by the silanization/hydrosilation method for use in HPLC [70]. As in the HPLC experiments, this column was best suited for the resolution of the optical isomers of dinitrobenzoyl methyl esters of amino acids. The best separation (a = 1.14) was obtained for the alanine derivative. In addition, the peak symmetry and efficiency for the naphthylethylamine column was significantly better than that obtained on the cyclodextrin column. However, as shown in HPLC experiments, changes in the amino acid moiety (replacing alanine with valine, etc.) often results in a loss of chiral resolution. In the case of optical isomers, the separation mechanism in HPLC and CEC modes is identical since only interaction between the solute and the bonded phase can result in resolution of the enantiomers. 

Now see what happens if we replace the achiral benzyl ester group with an amide derived from the natural amino acid valine (Chapter 49). The diastereoselectivity remains the same but the chiral environment created by the single enantiomer covalently bonded to the dienophile has a remarkable effect only one enantiomer of the product is formed. 

This structure was modified by replacing one of the hydrogens on each of the NH2 groups. The most potent inhibitor in this series had both hydrogens replaced by cbz—Val (Structure 4.6), the amino acid valine protected by a protecting group whose trivial name is carbobenzoxy. 

Synthesis of glutamate removes a-ketoglutarate from the TCA cycle, thereby decreasing the regeneration of oxaloacetate in the TCA cycle. Because oxaloacetate is necessary for the oxidation of acetyl CoA, oxaloacetate must be replaced by anapierotic reactions. There are two major types of anapierotic reactions (1) pyruvate carboxylase and (2) the degradative pathway of the branched-chain amino acids, valine and isoleucine, which contribute succinyl CoA to the TCA cycle. This pathway uses B12 (but not folate) in the reaction catalyzed by methylmalonyl CoA mutase. 

Fig. 1. Amino acid sequence for the A- and B-chains of human iasulin [11061-68-0] where soHd lines denote disulfide bonds. Porciae iasulin [12584-58-6] differs by one amino acid ia the B-chaia where alanine replaces threonine at positioa 30. Boviae iasulia [11070-73-8] differs by three amino acids. la the A-chain alanine replaces the threonine at positioa 8 and valine replaces the isoleuciae at position 10. In the B-chain there is an alanine at position 30.

The elegant genetic studies by the group of Charles Yanofsky at Stanford University, conducted before the crystal structure was known, confirm this mechanism. The side chain of Ala 77, which is in the loop region of the helix-turn-helix motif, faces the cavity where tryptophan binds. When this side chain is replaced by the bulkier side chain of Val, the mutant repressor does not require tryptophan to be able to bind specifically to the operator DNA. The presence of a bulkier valine side chain at position 77 maintains the heads in an active conformation even in the absence of bound tryptophan. The crystal structure of this mutant repressor, in the absence of tryptophan, is basically the same as that of the wild-type repressor with tryptophan. This is an excellent example of how ligand-induced conformational changes can be mimicked by amino acid substitutions in the protein. 

As the name implies, the odor of urine in maple syrup urine disease (brancbed-chain ketonuria) suggests maple symp or burnt sugar. The biochemical defect involves the a-keto acid decarboxylase complex (reaction 2, Figure 30-19). Plasma and urinary levels of leucine, isoleucine, valine, a-keto acids, and a-hydroxy acids (reduced a-keto acids) are elevated. The mechanism of toxicity is unknown. Early diagnosis, especially prior to 1 week of age, employs enzymatic analysis. Prompt replacement of dietary protein by an amino acid mixture that lacks leucine, isoleucine, and valine averts brain damage and early mortality. 

Not all proteins are nutritionally equivalent. Mote of some than of others is needed to maintain nittogen balance because different proteins contain different amounts of the various amino acids. The body s requirement is for specific amino acids in the correct proportions to replace the body proteins. The amino acids can be divided into two groups essential and nonessential. There are nine essential or indispensable amino acids, which cannot be synthesized in the body histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, and valine. If one of these is lacking or inadequate, then—regardless of the total intake of protein—it will not be possible to maintain nitrogen balance since there will not be enough of that amino acid for protein synthesis. 

Now we can ask what is likely to happen to the three-dimensional structure of a protein if we make a conservative replacement of one amino acid for another in the primary structnre. A conservative replacement involves, for example, substitution of one nonpolar amino acid for another, or replacement of one charged amino acid for another. Intnitively, one would expect that conservative replacements would have rather little effect on three-dimensional protein structure. If an isoleucine is replaced by a valine or leucine, the structnral modification is modest. The side chains of all of these amino acids are hydrophobic and will be content to sit in the molecnlar interior. This expectation is borne out in practice. We have noted earlier that there are many different molecnles of cytochrome c in nature, all of which serve the same basic function and all of which have similar three-dimensional structnres. We have also noted the species specificity of insulins among mammalian species. Here too we find a number of conservative changes in the primary structure of the hormone. Although there are exceptions, as a general rule conservative changes in the primary structnre of proteins are consistent with maintenance of the three-dimensional structures of proteins and the associated biological functions. 

Amino acid replacements in proteins may be conservative that is, an amino acid of one class is replaced by another of the same class, e.g., alanine is replaced by valine. Conservative replacements frequently have little impact on protein structure or function. 

Various amino acids have been replaced by 4-F-Phe or hexafluorovaline in peptidic hormones oxytocin (4-F-Phe —> lyr), bradykinin (4-F-Phe —> Phe), and angiotensin II. The consequences are diverse, but the stability toward hydrolytic enzymes is generally enhanced. Thus, incorporation of Fs-valine in an octapeptide antagonist of angiotensin II (Sar-AII) notably enhances its in vivo antagonist activity. Analogues of TRH (thyrotropin-releasing hormone), in which histidine is replaced by a fluor-ohistidine (4-F-His and 2-F-His —> His), have better in vivo activities, while the affinities are lower. 

However, it is clear from this that activation of an oncogene may only require a point mutation in the proto-oncogene sequence (e.g., H-ras, G to T in reading frame). This would mean that glycine was replaced with valine. All Ras oncoproteins have amino acid substitution in residues 12, 61, or 13. 

---